| scholarly article | Q13442814 |
| P2093 | author name string | Fatima Rizvi | |
| Moosa Khan | |||
| Farah Asad | |||
| P2860 | cites work | Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial | Q33940282 |
| Clinical improvement in psoriasis with treatment of associated hyperlipidemia | Q34158912 | ||
| A review on laboratory liver function tests | Q34321014 | ||
| Psoriasis assessment tools in clinical trials | Q35579443 | ||
| The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis | Q36077729 | ||
| Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis | Q36124545 | ||
| Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia | Q36139098 | ||
| Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. | Q36334747 | ||
| Pathogenesis and therapy of psoriasis | Q36742020 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| C-reactive protein and uric Acid levels in patients with psoriasis | Q38266480 | ||
| Dyslipidemia in Psoriasis: A Case Controlled Study | Q42119545 | ||
| Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. | Q42495512 | ||
| Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. | Q45939260 | ||
| A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand | Q46880378 | ||
| Atorvastatin for the treatment of plaque-type psoriasis. | Q50998182 | ||
| Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS). | Q54326002 | ||
| P433 | issue | 6 | |
| P921 | main subject | betamethasone | Q416132 |
| P304 | page(s) | 1507-1511 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Pakistan Journal of Medical Sciences | Q15752320 |
| P1476 | title | Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis | |
| P478 | volume | 33 |
Search more.